AACP
CORZ icon

Advantage Alpha Capital Partners’s Core Scientific CORZ Stock Holding History

Advantage Alpha Capital Partners’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-66,685
Closed -$1.2M – 30
2025
Q3 		$1.2M Sell
66,685
-14,884
-18% -$218K 0.36% 97
2025
Q2 		$1.39M Sell
81,569
-19,269
-19% -$193K 0.38% 90
2025
Q1 		$730K Sell
100,838
-33,264
-25% -$379K 0.18% 92
2024
Q4 		$1.88M Buy
+134,102
New +$1.98M 0.44% 87

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Advantage Alpha Capital Partners's CORZ Position: Q4 2025 in Review

Advantage Alpha Capital Partners sold out of Core Scientific (CORZ) in Q4 2025, closing a stake of 66,685 shares — an estimated $1.2M sold.

Advantage Alpha Capital Partners first reported a position in CORZ in Q4 2024 and held it in 4 quarters. The position peaked at $1.88M in Q4 2024. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

  • Advantage Alpha Capital Partners reported no remaining Core Scientific position as of Q4 2025 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 66,685 Core Scientific shares in Q4 2025, an estimated $1.2M.
  • Advantage Alpha Capital Partners first reported a position in Core Scientific in Q4 2024 and held it in 4 quarters.
  • Advantage Alpha Capital Partners's Core Scientific position peaked at $1.88M in Q4 2024.
  • 367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.